SBC Medical Group Holdings (SBC) Sidoti Small-Cap Virtual Investor Conference summary
Event summary combining transcript, slides, and related documents.
Sidoti Small-Cap Virtual Investor Conference summary
18 Jun, 2026Business model and operations
Operates as a Medical Services Organization, centrally managing marketing, procurement, technology, hiring, and training for clinics, enabling scalability and growth alongside clinic expansion.
Portfolio includes multiple brands across beauty and general healthcare, such as hair loss, fertility, orthopedics, eye care, and dental services, serving 6.7 million customers annually through 284 clinics.
Multi-brand strategy and data-driven approach foster long-term patient relationships and create a significant competitive moat built over 26 years.
Financial performance and underlying growth
Q1 2026 revenue was JPY 43 million, a 9% year-over-year decline due to a fee structure revision, which reduced franchising and management service revenues.
Net income declined year-over-year, partly due to a prior one-time life insurance gain; underlying revenue and EBITDA grew 11% and 17% year-over-year, respectively, when adjusted for structural changes.
Strategic initiatives and growth drivers
Focused on longevity through both aesthetic and general medical services, with the launch of SBC Wellness and upcoming SBC Wellness 2.0 targeting corporate clients.
Leveraging 26 years of expertise, a large clinic network, and extensive patient data to lead the emerging longevity market, especially via corporate channels.
Expanding operational capabilities from aesthetic medicine into broader healthcare categories, applying standardized management and dual cash/insurance models.
Latest events from SBC Medical Group Holdings
- AI-driven growth, global expansion, and multi-brand strategies fuel accelerating performance.SBC
Small-Cap Virtual Conference - Profit and revenue surged as AI, new formats, and global expansion fueled renewed growth.SBC
Q3 Investor Summit Group Virtual Conference 2026 - Q2 2026 saw accelerated growth, AI-driven efficiency, and expansion in healthcare and global markets.SBC
Emerging Growth Conference - Leading Japanese aesthetic clinic group achieves rapid global growth and strong financial results.SBC
Corporate presentation - Q2 2026 net income surged 335% on 13% revenue growth, fueled by AI and network expansion.SBC
Q2 2026 - All director nominees and charter amendments were approved at the virtual annual meeting.SBC
AGM 2026 - AI-driven, multi-brand healthcare model targets global expansion and double-digit growth.SBC
Emerging Growth Conference 93 - Largest aesthetic clinic network in Japan, expanding globally with high growth and profitability.SBC
Investor presentation - Strong financials, global expansion, and strategic initiatives drive growth and shareholder value.SBC
Life Sciences Investor Forum